Evotec Appoints Rui Wang as Head of Global In Silico and AI

Evotec SE has announced Rui Wang as the new Executive Vice President, Head of Global In Silico and AI. With over two decades of experience in pharma and biotech industries, Wang will lead AI-driven strategies at Evotec. His focus will be on integrating computational science and data-driven decision-making across the company's R&D operations.

Prior to joining Evotec, Wang held significant roles at AstraZeneca and the European Bioinformatics Institute. He aims to leverage Evotec's unique position in discovery, data, and proprietary platforms. This appointment underscores Evotec's commitment to enhancing drug discovery and development through advanced computational tools and innovation.